Although some evidence supported that PHGDH enhanced proliferation, migration and invasion of pancreatic cancer [36], and contributed to the resistance of sorafenib and other tyrosine kinase inhibitors in hepatocellular carcinoma [37]. The gene discussed is PHGDH; the disease is hepatocellular carcinoma.